ID23307A - Polimorf zopolrestat monohidrat - Google Patents

Polimorf zopolrestat monohidrat

Info

Publication number
ID23307A
ID23307A IDP990796A ID990796A ID23307A ID 23307 A ID23307 A ID 23307A ID P990796 A IDP990796 A ID P990796A ID 990796 A ID990796 A ID 990796A ID 23307 A ID23307 A ID 23307A
Authority
ID
Indonesia
Prior art keywords
polyoror
monohidrat
zopolrestat
zopolrestat monohidrat
polyoror zopolrestat
Prior art date
Application number
IDP990796A
Other languages
English (en)
Indonesian (id)
Inventor
John Francis Lambert
Timothy Norris
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ID23307A publication Critical patent/ID23307A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
IDP990796A 1998-08-21 1999-08-20 Polimorf zopolrestat monohidrat ID23307A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9747498P 1998-08-21 1998-08-21

Publications (1)

Publication Number Publication Date
ID23307A true ID23307A (id) 2000-04-05

Family

ID=22263562

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP990796A ID23307A (id) 1998-08-21 1999-08-20 Polimorf zopolrestat monohidrat

Country Status (31)

Country Link
US (1) US6159976A (is)
EP (1) EP0982306A3 (is)
JP (1) JP2000072769A (is)
KR (1) KR20000017411A (is)
CN (1) CN1245804A (is)
AP (1) AP9901662A0 (is)
AU (1) AU4453299A (is)
BG (1) BG103674A (is)
BR (1) BR9903873A (is)
CA (1) CA2280590A1 (is)
EA (1) EA199900675A3 (is)
EE (1) EE9900385A (is)
GT (1) GT199900137A (is)
HR (1) HRP990259A2 (is)
HU (1) HUP9902783A3 (is)
ID (1) ID23307A (is)
IL (1) IL131419A0 (is)
IS (1) IS5155A (is)
MA (1) MA26678A1 (is)
NO (1) NO994027L (is)
NZ (1) NZ337363A (is)
OA (1) OA11150A (is)
PA (1) PA8480601A1 (is)
PE (1) PE20000993A1 (is)
PL (1) PL335016A1 (is)
SG (1) SG83147A1 (is)
TN (1) TNSN99159A1 (is)
TR (1) TR199901996A2 (is)
UY (1) UY25668A1 (is)
YU (1) YU39899A (is)
ZA (1) ZA995297B (is)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2593456T3 (pl) 2010-07-16 2017-06-30 The Trustees Of Columbia University In The City Of New York Inhibitory reduktazy aldozowej i ich zastosowania
US8916563B2 (en) 2010-07-16 2014-12-23 The Trustees Of Columbia University In The City Of New York Aldose reductase inhibitors and uses thereof
WO2014126885A1 (en) * 2013-02-13 2014-08-21 Mylari Banavara L Water soluble salts of aldose reductase inhibitors for treatment of diabetic complications
IL283809B2 (en) 2016-06-21 2024-01-01 Univ Columbia Compounds for use in a method of treating neuropathy, retinopathy, nephropathy, or cardiomyopathy
IL272246B2 (en) 2017-07-28 2026-01-01 Applied Therapeutics Inc History of 2-(4-oxo/thioketone/azo-3-((substituted)benzo[d]thiazol-2-yl)methyl)- 3,4-dihydrothieno[3,4-d]pyridazin-1-yl)acetic acid for use as an aldose reductase inhibitor for the treatment of galactosemia or prevention of galactosemia-related complications
AU2020254610A1 (en) 2019-04-01 2021-11-18 Applied Therapeutics Inc. Inhibitors of aldose reductase
CN113966396A (zh) 2019-05-07 2022-01-21 迈阿密大学 遗传性神经病和相关障碍的治疗和检测
EP4125909A1 (en) 2020-03-31 2023-02-08 Applied Therapeutics Inc. Aldose reductase inhibitors for the treatment of acute respiratory distress syndrome, acute lung inflammation/injury, cardiac injury and anti-viral therapy
CN115996725A (zh) 2020-05-01 2023-04-21 应用治疗公司 用于治疗山梨糖醇脱氢酶缺乏症的醛糖还原酶抑制剂
US20230322786A1 (en) * 2020-09-08 2023-10-12 Teva Pharmaceuticals International Gmbh Solid state forms of at-001 and process for preparation thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4748280A (en) * 1985-11-07 1988-05-31 Pfizer Inc. Certain chlorination process for preparing 2-chloro-1,1,1-(C1 -C6)
US4939140A (en) * 1985-11-07 1990-07-03 Pfizer Inc. Heterocyclic oxophthalazinyl acetic acids
US4868301A (en) * 1987-06-09 1989-09-19 Pfizer Inc. Processes and intermediates for the preparation of oxophthalazinyl acetic acids having benzothiazole or other heterocyclic side chains
JPH0676391B2 (ja) * 1987-06-09 1994-09-28 フアイザー・インコーポレイテツド ベンゾチアゾール等の複素環側鎖を有するオキソフタラジニル酢酸類の製造方法
US4904782A (en) * 1988-02-29 1990-02-27 Pfizer Inc. Process for the production of phthalazineacetic acid ester derivatives and a novel intermediate
US4954629A (en) * 1989-05-11 1990-09-04 Pfizer Inc. Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof
WO1992003432A1 (en) * 1990-08-28 1992-03-05 Pfizer Inc. 3-(5-trifluoromethylbenzothiazol-2-ylmethyl)-4-oxo-3h-phythalazin-1-ylacetic acid monohydrate
US5391551A (en) * 1993-05-10 1995-02-21 Pfizer Inc. Method of lowering blood lipid levels
IL120264A0 (en) * 1996-02-29 1997-06-10 Pfizer Method of reducing tissue damage associated with non-cardiac ischemia

Also Published As

Publication number Publication date
IS5155A (is) 2000-02-22
PL335016A1 (en) 2000-02-28
ZA995297B (en) 2001-02-19
AU4453299A (en) 2000-03-09
SG83147A1 (en) 2001-09-18
HUP9902783A2 (hu) 2000-12-28
EA199900675A2 (ru) 2000-02-28
HU9902783D0 (en) 1999-10-28
HRP990259A2 (en) 2000-06-30
TNSN99159A1 (fr) 2005-11-10
PE20000993A1 (es) 2000-10-04
TR199901996A2 (xx) 2000-03-21
BR9903873A (pt) 2000-09-19
NO994027D0 (no) 1999-08-20
CA2280590A1 (en) 2000-02-21
NO994027L (no) 2000-02-22
HUP9902783A3 (en) 2001-01-29
BG103674A (en) 2000-03-31
EP0982306A3 (en) 2000-07-05
EA199900675A3 (ru) 2000-06-26
PA8480601A1 (es) 2000-09-29
MA26678A1 (fr) 2004-12-20
GT199900137A (es) 2001-02-09
CN1245804A (zh) 2000-03-01
JP2000072769A (ja) 2000-03-07
UY25668A1 (es) 2001-08-27
KR20000017411A (ko) 2000-03-25
EP0982306A2 (en) 2000-03-01
YU39899A (sh) 2002-12-10
US6159976A (en) 2000-12-12
NZ337363A (en) 2001-01-26
OA11150A (en) 2003-04-16
AP9901662A0 (en) 1999-09-30
EE9900385A (et) 2000-04-17
IL131419A0 (en) 2001-01-28

Similar Documents

Publication Publication Date Title
ID29066A (id) Turunan fenilglisina
ID27423A (id) Turunan kuinolin
DE69919529D1 (de) Lungevenenablationskatheter
ID23234A (id) Turunan-turunan benzosulfona
DE69940286D1 (de) Brenstoffzellenstapel
IS5585A (is) Lyfjaskömmtunarbúnaðir
ID27484A (id) Turunan adenosina
DE69919117D1 (de) Seilklemme
ID27547A (id) Turunan kuinolin
ID24221A (id) Tempat patrum
DE69910986D1 (de) Atmosphärenteilchenanalysator
ID27049A (id) Tienopirimidin-tienopirimidin
DE69904737D1 (de) Streifenkodelesegerät
DE69922449D1 (de) Bandeinfädlungsvorrichtung
DE69932936D1 (de) Atemabsaugkathetervorrichtung
DE69922729D1 (de) Achsschubausgleich
DE69938476D1 (de) Münzschiebespielgerät
FI980739A0 (fi) Timmerknut
FI980187A0 (fi) Vattenturbinsystem
EA199900675A3 (ru) Полиморф моногидрата зополрестата
ID28356A (id) Turunam tiazola
DE69935559D1 (de) Bussignalleitungstreiber
DE69907543D1 (de) Röhrchenindexiervorrichtung
FI980335A0 (fi) Statisk elenergimaetare
DE69905102D1 (de) Spritzgiessmaschinensteuerung